lmfin 90 - tittels., forord, innledn - Nasjonalt folkehelseinstitutt
lmfin 90 - tittels., forord, innledn - Nasjonalt folkehelseinstitutt
lmfin 90 - tittels., forord, innledn - Nasjonalt folkehelseinstitutt
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Hovedinndeling i ATC gruppe C - Hjerte og kretsløp/<br />
Main ATC levels in C - Cardiovascular system<br />
C01 Hjerteterapi/Cardiac therapy<br />
C02 Antihypertensiva/Anithypertensives<br />
C03 Diuretika/Diuretics<br />
C04 Perifere kardilaterende midler/Peripheral vasodilators<br />
C05 Vasoprotektorer (utelatt)/Vasoprotectives (not included)<br />
C07 Betablokkere/Beta blocking agents<br />
C08 Kalsiumantagonister/Calcium channel blockers<br />
50<br />
ATC gruppe C<br />
C09 Midler med virkning på renin-angiotensinsystemet/Agents acting on the renin-angiotensin system<br />
C10 Lipidmodifiserende midler/Lipid modifying agents<br />
Salg pr ATC 3. nivå for gruppe C - Hjerte og kretsløp<br />
Sales per ATC 3rd level for ATC group C - Cardiovascular system<br />
mill NOK (AUP)<br />
ATC ATC level name 2003 2004 2005 2006 2007<br />
C01A Cardiac glycosides 6,6 7,6 7,2 8,6 9,2<br />
C01B Antiarrhythmics, class I and III 22,7 18,7 19,8 20,1 21,3<br />
C01C Cardiac stimulants excl. cardiac glycosides 13,5 15,4 18,4 20,0 21,0<br />
C01D Vasodilators used in cardiac diseases 85,6 81,5 73,2 65,5 60,5<br />
C01E Other cardiac preparations 1,2 1,2 1,2 1,0 1,2<br />
C02A Antiadrenergic agents, centrally acting 9,4 9,8 10,1 10,7 9,8<br />
C02C Antiadrenergic agents, peripherally acting 76,5 45,3 38,6 29,6 26,0<br />
C02D Arteriolar smooth muscle, agents acting on 0,3 0,3 0,3 0,3 0,3<br />
C02K Other antihypertensives 4,9 15,0 22,1 21,9 18,6<br />
C03A Low-ceiling diuretics, thiazides 6,8 11,3 15,9 19,9 23,3<br />
C03C High-ceiling diuretics 51,9 60,0 59,7 56,2 58,7<br />
C03D Potassium-sparing agents 8,9 8,9 9,3 10,4 11,7<br />
C03E Diuretics and potassium-sparing agents in<br />
7,8 8,5 7,3 7,3 7,4<br />
combination<br />
C04A Peripheral vasodilators 5,2 4,7 3,7 2,3 2,0<br />
C07A Beta blocking agents 255,7 268,5 259,2 258,5 238,7<br />
C07B Beta blocking agents and thiazides 0,9 2,7 4,4 4,6 4,3<br />
C08C Selective calcium channel blockers with mainly<br />
vascular effect<br />
289,3 243,5 149,0 142,2 145,0<br />
C08D Selective calcium channel blockers with direct 42,6 39,8 35,8 31,9 30,3<br />
cardiac effects<br />
C09A ACE-inhibitors, plain 177,3 135,9 77,3 80,2 65,9<br />
C09B ACE-inhibitors, combinations 67,8 57,1 35,2 29,8 26,2<br />
C09C Angiotensin II antagonists, plain 267,3 293,5 324,5 330,0 358,7<br />
C09D Angiotensin II antagonists, combinations 247,7 301,1 364,6 3<strong>90</strong>,1 430,9<br />
C10A Lipid modifying agents, plain 1091,3 970,4 807,4 646,5 532,8<br />
C10B Lipid modifying agents, combinations 0,02 0,00
Change language